Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Free Research Reports on AFFY, BKS, DVAX and ENDP Issued by the Bedford Report Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT


Print article Print article
© Marketwire 2013
2013-02-26 14:21:30 -

NEW YORK, NY -- (Marketwire) -- 02/26/13 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.



Affymax, Inc. (NASDAQ: AFFY) shares hit a new 52-week low of $2.34 after declining over 85 percent on nearly 55 million shares traded Monday. The company announced a nationwide voluntary recall of its OMONTYS (peginesatide) Injection following reports of "serious hypersensitivity reactions."



Find out more about Affymax including full access to the free equity report at: www.BedfordReport.com/AFFY : www.bedfordreport.com/AFFY





Barnes & Noble, Inc. (NYSE: BKS) shares surged 11 percent on more than 4 times the average daily volume Monday. According the numerous reports the Barnes & Noble's founder and chairman, Leonard Riggio, has shown interest in buying out the company's consumer-bookstore chain, raising speculation that the company could be split into two separate units.



Find out more about Barnes & Noble including full access to the free equity report at: www.BedfordReport.com/BKS : www.bedfordreport.com/BKS



Dynavax Technologies Corporation (NASDAQ: DVAX) shares declined nearly 30 percent on more than six times its average daily volume Friday. The company announced that the FDA has stated that their investigational adult hepatitis B vaccine, HEPLISAV, cannot be approved for use in adults 18-70 years of age without further evaluation of safety.



Find out more about Dynavax Technologies including full access to the free equity report at: www.BedfordReport.com/DVAX : www.bedfordreport.com/DVAX



Endo Health Solutions Inc. (NASDAQ: ENDP) shares spiked over 9 percent on more than three times the average daily volume Monday. The company announced that Rajiv De Silva, who had previously been President of Valeant Pharmaceuticals and a senior executive at Novartis, would become Endo's President and Chief Executive Officer, effective March 18th.



Find out more about Endo Health Solutions including full access to the free equity report at: www.BedfordReport.com/ENDP : www.bedfordreport.com/ENDP



Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.



A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.




Contact Information:

Equity News Circuit
Email Contact : www2.marketwire.com/mw/emailprcntct?id=4041F5078B7FE7A8



Press Information:




Contact Person:


Disclaimer: (c) 2014 Market Wire. All of the press releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Market Wire's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com